人工肝脏支持系统与乙型肝炎病毒相关的急性至慢性肝衰竭的预后之间的关联
Kunping Cui1, Chang-Hai Liu1, Xiangnan Teng1
1Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.
Infection and drug resistance
|January 13, 2025
概括
人工肝脏支持系统 (ALSS) 在改善B型肝炎末期急性至慢性肝衰竭 (HBV-ACLF) 患者的存活率方面表现有前途. 与标准医学疗法 (SMT) 相比,ALSS治疗显著降低了这一特定子组的死亡率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 关键护理医学 关键护理医学
- 人工器官技术的人工器官技术
背景情况:
- 急性至慢性肝衰竭 (ACLF) 是一个重大的临床挑战,死亡率高.
- 人工肝脏支持系统 (ALSS) 正在被探索为ACLF患者的治疗选择.
- 在与乙型肝炎相关的ACLF (HBV-ACLF) 中ALSS的疗效仍然是正在进行的调查和辩论的主题.
研究的目的:
- 研究ALSS治疗与HBV-ACLF患者的短期预后之间的关联.
- 为了确定ALSS是否改善HBV-ACLF的无移植生存率.
- 确定HBV-ACLF患者的特定亚组,他们可能从ALSS治疗中获益最多.
主要方法:
- 追溯观察队列研究,包括589名HBV-ACLF患者.
- 接受ALSS和接受标准医学治疗 (SMT) 的患者之间的结局的比较.
- 使用卡普兰-梅尔生存分析和考克斯回归模型对28日,60日和90日无移植死亡率的分析.
主要成果:
- 与SMT相比,ALSS治疗与28日,60日和90日无移植死亡率显著降低有关.
- 这些生存益处主要观察到HBV-ACLF末期肝病患者的亚组 (PT-INR≥2.5).
- 总的来说,ALSS在整个HBV-ACLF患者群中没有显著的益处.
结论:
- ALSS在改善末期HBV-ACLF患者的短期预后方面表现出有效性.
- 治疗ALSS的好处是特定于最严重的HBV-ACLF病例.
- 可能需要进一步的研究来优化ALSS在特定患者群体中的应用.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42


